Insulet (PODD) Other Non-Current Assets (2010 - 2026)
Insulet's (PODD) quarterly Other Non-Current Assets came in at $280.6 million in Q1 2026, down 12.01% YoY from $318.9 million in Q1 2025, and down 2.64% on a QoQ basis from $288.2 million in Q4 2025.
Insulet (PODD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Other Non-Current Assets data on file, last reported at $280.6 million in Q1 2026.
- Quarterly Other Non-Current Assets fell 12.01% year-over-year to $280.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280.6 million (down 12.01% YoY) and the FY2025 annual result came in at $288.2 million, up 58.79% from the prior year.
- Other Non-Current Assets retreated to $280.6 million in Q1 2026, from $288.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $318.9 million in Q1 2025 to a low of $141.0 million in Q1 2022.
- A 5-year average of $211.1 million and a median of $188.3 million in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 97.93% — and 2024, when it dropped 22.68%.
- Tracing PODD's Other Non-Current Assets over 5 years: stood at $210.0 million in 2022, then slipped by 10.38% to $188.2 million in 2023, then fell by 3.56% to $181.5 million in 2024, then surged by 58.79% to $288.2 million in 2025, then dropped by 2.64% to $280.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $280.6 million (Q1 2026), $288.2 million (Q4 2025), and $188.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Insulet | 10.18 Bn | 9.64 Bn | 562.60 Mn | 290.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 290.80 Mn |
| Mar 31, 2026 | 280.60 Mn |
| Dec 31, 2025 | 288.20 Mn |
| Sep 30, 2025 | 188.30 Mn |
| Jun 30, 2025 | 315.10 Mn |
| Mar 31, 2025 | 318.90 Mn |
| Dec 31, 2024 | 181.50 Mn |
| Sep 30, 2024 | 165.90 Mn |
| Jun 30, 2024 | 163.60 Mn |
| Mar 31, 2024 | 187.70 Mn |
| Dec 31, 2023 | 188.20 Mn |
| Sep 30, 2023 | 196.20 Mn |
| Jun 30, 2023 | 211.60 Mn |
| Mar 31, 2023 | 210.60 Mn |
| Dec 31, 2022 | 210.00 Mn |
| Sep 30, 2022 | 178.70 Mn |
| Jun 30, 2022 | 161.90 Mn |
| Mar 31, 2022 | 141.00 Mn |
| Dec 31, 2021 | 106.10 Mn |
| Sep 30, 2021 | 99.60 Mn |